The metoclopramide black box warning for tardive dyskinesia: effect on clinical practice, adverse event reporting, and prescription drug lawsuits

The American Journal of Gastroenterology
Eli D EhrenpreisJerrold B Leikin

Abstract

We examined the effects of the black box warning about the risk of tardive dyskinesia (TD) with chronic use of metoclopramide on management of gastroparesis within a single clinical practice, and on reporting of adverse events. Medical records of gastroparesis patients were evaluated for physician management choices. The FDA Adverse Event Reporting System (FAERS) was analyzed for event reports, and for lawyer-initiated reports, with metoclopramide from 2004 to 2010. Google Scholar was searched for court opinions against metoclopramide manufacturers. Before the black box warning, 69.8% of patients received metoclopramide for gastroparesis, compared with 23.7% after the warning. Gastroenterologists prescribed domperidone more often after than before the warning. Metoclopramide prescriptions decreased after 2008. Adverse event reporting increased after the warning. Only 3.6% of all FAERS reports but 70% of TD reports were filed by lawyers, suggesting a distortion in signal. Forty-seven legal opinions were identified, 33 from 2009-2010. The black box warning for metoclopramide has decreased its usage and increased its rate of adverse event reporting. Lawyer-initiated reports of TD hinder pharmacovigilance.

References

Aug 14, 2002·Journal of Clinical Pharmacy and Therapeutics·A K WagnerD Ross-Degnan
Sep 10, 2004·The New England Journal of Medicine·Wayne A RayC Michael Stein
Mar 24, 2006·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·Thomas L AbellA I Vinik
Jan 9, 2008·Archives of General Psychiatry·Mark OlfsonBenjamin G Druss
Apr 9, 2008·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Laurence Y KatzJitender Sareen
Jun 3, 2009·Archives of General Psychiatry·Anne M LibbyRobert J Valuck
Jan 13, 2010·Archives of Internal Medicine·E Ray DorseyG Caleb Alexander
Sep 24, 2011·European Journal of Gastroenterology & Hepatology·Deepak ParakkalEli D Ehrenpreis
Apr 6, 2012·The American Journal of Gastroenterology·Eli D EhrenpreisFDA-Related Matters Committee of the American College of Gastroenterology

Citations

Mar 29, 2014·Expert Opinion on Emerging Drugs·William L Hasler
Mar 27, 2015·Expert Opinion on Investigational Drugs·Thomas Müller
Sep 8, 2017·Current Treatment Options in Gastroenterology·Allen A Lee, William L Hasler
Oct 4, 2017·Expert Review of Neurotherapeutics·Thomas Müller
Sep 4, 2017·European Journal of Clinical Pharmacology·Antoine ParienteBernard Bégaud
Feb 15, 2018·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·J R GiudicessiM Camilleri
Sep 27, 2014·Digestive Diseases and Sciences·Anwar DudekulaKlaus Bielefeldt
Aug 30, 2014·Current Treatment Options in Gastroenterology·Benjamin SteinBrian E Lacy
Mar 26, 2015·Journal of Pediatric Gastroenterology and Nutrition·Jessica E EricsonBest Pharmaceuticals for Children Act–Pediatric Trials Network Administrative Core Committee
Jun 5, 2015·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Christoph U CorrellMarc De Hert
Nov 20, 2016·Anesthesia and Analgesia·Carsten StoetzerAndreas Leffler
May 3, 2019·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·Ahmad Al-SaffarPer M Hellström
May 7, 2015·Current Opinion in Pediatrics·Saleem Islam
Jun 24, 2018·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Sathya Krishnasamy, Thomas L Abell
Jun 8, 2018·Journal of Clinical Gastroenterology·Thomas J DownesAdam D Farmer
Aug 2, 2018·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·James R RogersJohn G Connolly
Mar 31, 2016·Journal of Clinical Psychopharmacology·Anatoly KreininVladimir Lerner
Apr 23, 2014·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·J BroadG J Sanger
Mar 21, 2020·Current Gastroenterology Reports·Amol SharmaHenry P Parkman
Jun 5, 2018·F1000Research·Patrick McKenzie, Klaus Bielefeldt
Jul 2, 2019·Therapeutic Advances in Drug Safety·Chien-Hsu LaiYen-Yu Chen
Sep 10, 2017·Current Gastroenterology Reports·Eamonn M M Quigley
Sep 10, 2020·Risk Management and Healthcare Policy·Hyungtae Kim, Hae Sun Suh

Related Concepts

Domperidone Maleate (1: 1)
Drug Labeling
Rimetin
Etat Marbre
Prescribing Patterns, Physician
Torts
Adverse Drug Reaction Reporting Systems
Dopamine Antagonists
Gastroparesis
Pharmacovigilance

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Synthetic Genetic Array Analysis

Synthetic genetic arrays allow the systematic examination of genetic interactions. Here is the latest research focusing on synthetic genetic arrays and their analyses.

Congenital Hyperinsulinism

Congenital hyperinsulinism is caused by genetic mutations resulting in excess insulin secretion from beta cells of the pancreas. Here is the latest research.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Epigenetic Memory

Epigenetic memory refers to the heritable genetic changes that are not explained by the DNA sequence. Find the latest research on epigenetic memory here.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Femoral Neoplasms

Femoral Neoplasms are bone tumors that arise in the femur. Discover the latest research on femoral neoplasms here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Related Papers

Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
P R Latimer
Alimentary Pharmacology & Therapeutics
A S Rao, M Camilleri
The Journal of Clinical Psychiatry
Stanley N CaroffCATIE Investigators
The Annals of Pharmacotherapy
Leigh Anne NelsonSarah N Hausafus
The Annals of Pharmacotherapy
K H BoomershineJ E Boomershine
© 2021 Meta ULC. All rights reserved